International Society for Hemodialysis™ (ISHD)
Hemodialysis UniversityŽ

August 15 - 16, 2014, Chicago, Illinois USA
     HDCN free zone registration is required.
PART FIVE. Venous Catheters and Patient Reported Outcomes
Management Of Infected Venous Dialysis Catheters–2014 Update
Michele Mokrzycki, MD
Temporary Hemodialysis Catheters: Recent Advances
Ted Clark, MD
Drs. Mokrzycki, and Clark
The Power Of Collecting And Analyzing Patient Reported Outcomes
Chris McIntyre, MD

Michele H. Mokrzycki, MD
Professor of Clinical Medicine
Department of Nephrology
Albert Einstein College of Medicine of Yeshiva University
Bronx, New York

Chris McIntyre, MD
Professor of Nephrology
Head of Division of Medical Sciences and
Graduate Entry Medicine
School of Medicine
Faculty of Medicine & Health Sciences
University of Nottingham
Royal Derby Hospital Centre
Derby, United Kingdom

Edward (Ted) Clark, MD
Division of Nephrology
The Ottawa Hospital and Kidney Research Centre
Ottawa Hospital Research Institute
Ottawa, Ontario, Canada
The live program on which this Web-based educational activity is based was supported by educational grants from Fresenius Medical Care, Dialysis Centers Inc, Baxter Healthcare, and Amgen. No industry funding was provided for support of the Web-based program.

Program Overview
This program will discuss on clinically important problems in dialysis, including home hemodialysis (prescription and delivery), complexities of anemia management, pathogenesis and implications of newly recognized unique complications of hemodialysis, and the value of reporting and analysis of patient reported outcomes in improving quality of hemodialysis.

The program is also aimed at improving the overall level of hemodialysis, and provide a good platform for learning and engage in international exchanges hemodialysis doctors, nurses and engineers.

Educational Objectives
Upon completion of this activity, the participants should be able to:
  • HOME HEMODIALYSIS: Describe methods used to select and train patients for home hemodialysis, manage vascular access, home modification for home hemodialysis, equipment maintenance, remote monitoring, adequacy, and patient safety.
  • ANEMIA: Discuss best practices regarding management of anemia in hemodialysis patients including indications for transfusions, hemoglobin targets, iron use, and anemia management algorithms.
  • Assess how to recognize the “DARK SIDE OF HEMODIALYSIS”, i.e. hemodialysis complications like myocardial and brain stunning, individualized dialysate temperature and cool dialysate.
  • Evaluate ANALYTICAL TECHNIQUES for reporting patient reported outcomes.
Target Audience
This program is designed for health professionals involved in dialysis programs, primarily nephrologists, nephrology fellows, nephrology nurses and nurse practitioners, and patient care technicians.

Physician and Nursing Credit
Although the live programs were prepared under CME accreditation guidelines, no CME/CE credit is available for participating in this Web-archived activity.

Disclosure Policy
Each speaker has completed and signed a conflict of interest statement. The faculty members' relationship will be disclosed in the course materials.

Michele Mokrzycki, MD, receives consulting fees as a Clinical Events Committee Member for Medtronics.

Edward (Ted) Clark, MD, receives a salary from Nephrology Physicians of Ottawa.

Chris McIntyre, MD, receives grants/research support from Baxter and Fresenius, and consulting fees from Baxter, Fresenius, Braun, Sanofi, and Astra Zeneca.

Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program. The information presented at this program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, HDCN or the ISHD. Each participant must use his/her personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses. Before prescribing any medicine, primary references and full prescribing information should be consulted.
This website is managed by HDCN, and their printed privacy policy applies to this site.

The policy statements of HDCN are listed on this page.